SCHEMBL3887258

SCHEMBL3887258

COS(=O)(=O)[O-].COc1cc(C=C2C(=O)N(c3cccc[n+]3C)N=C2C)ccc1O

nearest known ligand 0.53

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 13/20 0.53
L3MBTL1 Q9Y468 4/20 0.53
POLB P06746 2/20 0.53
MEN1 O00255 10/20 0.53
ALDH1A1 P00352 7/20 0.53
MAPT P10636 7/20 0.53
HPGD P15428 3/20 0.53
PKM P14618 2/20 0.53
HTT P42858 1/20 0.53
PTGS2 P35354 2/20 0.51
KDM4E B2RXH2 3/20 0.49
GAA P10253 2/20 0.49
THRB P10828 2/20 0.49
AMY1A P0DUB6 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
SAE1 Q9UBE0 2/20 0.47
UBA2 Q9UBT2 2/20 0.47
PSMD14 O00487 1/20 0.47
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3887256 1.00 KMT2A (0.53) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3889127 0.87 KMT2A (0.45) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3889124 0.87 KMT2A (0.45) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3885822 0.84 KMT2A (0.41) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3885818 0.84 KMT2A (0.41) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3889675 0.82 KMT2A (0.52) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3889681 0.82 KMT2A (0.52) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3888567 0.81 KMT2A (0.50) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3887766 0.81 KMT2A (0.50) KMT2AL3MBTL1POLBMEN1ALDH1A1
SCHEMBL3897763 0.81 KMT2A (0.43) KMT2AL3MBTL1POLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534273-B2 Cationic pyrazolone dyes, method for production thereof and coloring agents for keratin fibers containing said compounds WELLA AG (DE) 2009-05-19 US claimed
US-20080263787-A1 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2008-10-30 US claimed
US-7534273-B2 Cationic pyrazolone dyes, method for production thereof and coloring agents for keratin fibers containing said compounds WELLA AG (DE) 2009-05-19 US disclosed
US-20080263787-A1 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080263787-A1 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds KRT18, KLK5, IK KMT2A 3682/4885L3MBTL1 4866/4885POLB 2970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.